Skip to main content
Veterinary Medicines

Parofor 175 mg/ml Solution for injection

Suspended
  • Paromomycin sulfate

Product identification

Medicine name:
Parofor 175 mg/ml Solution for injection
Active substance:
  • Paromomycin sulfate
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Paromomycin sulfate
    250.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        20
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA06
Authorisation status:
  • Suspended
Authorised in:
  • France
Package description:
  • Parofor 175 mg/ml inj. sol. i.m. vial 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet J.S.C.
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/6651916 0/2019
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0027/003
Concerned member states:
  • Czechia
  • Denmark
  • Estonia
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)
Generic of:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 7/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."